Prior to this announcement, Roche Holding's dividend made up quite a large proportion of earnings but only 51% of free cash flows. This leaves plenty of cash for reinvestment into the business.

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The growth was driven by strong demand for new medicines, which offset ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

Sales in Roche’s pharmaceutical division grew 8% to CHF 46.2bn ($50.9bn). Credit: hapabapa via Getty Images. Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), ...

SINGAPORE: Shortly after the body of 39-year-old Audrey Fang was found in Spain on April… ...

Julia was a correspondent for Yahoo Finance.

If you have never heard of Simon Roche, and you very possibly haven’t, he is the official spokesman for the Suidlanders. The group, led by the reclusive Gustav Muller, is headquartered in the small ...

The latest Market Talks covering Technology, Media and Telecom. Published exclusively on Dow Jones Newswires at 4:20 ET, ...

At close: 11 February at 17:31:50 CET ...